Adrian Teo | Co-Founder
BetaLife Pte Ltd | Singapore

Adrian Teo, Co-Founder, BetaLife Pte Ltd

Adrian obtained his B.Sc. (1st Class) from the National University of Singapore. He completed his Ph.D. on stem cell biology with Ludovic Vallier at the University of Cambridge, under an A*STAR Scholarship.

Concurrently, he was also an Honorary Cambridge Commonwealth Trust Scholar. He then trained with Rohit Kulkarni at Joslin Diabetes Center, Harvard Medical School, as a Juvenile Diabetes Research Foundation fellow, on pancreatic islet biology and diabetes. Adrian is currently a Principal Investigator at the Institute of Molecular and Cell Biology, A*STAR, and an Assistant Professor at NUS Medicine, Singapore, using human pluripotent stem cells for disease modelling of diabetes. He is also a co-founder of BetaLife Pte Ltd focused on the use of stem cell therapy for diabetes patients. He is a member of the Oxbridge Society of Singapore, the International Society for Stem Cell Research and an EXCO member of the Stem Cell Society Singapore.


Phar East 2020 Agenda Day One @ 17:00

Clinical grade Asian human induced pluripotent stem cell-derived beta cells for diabetes therapy: Innovative Cell Therapy Platform for Asian Diabetes

last published: 09/Dec/20 03:45 GMT

back to speakers






For speaking, sponsorship and exhibition opportunities contact
Tel: +65 6322 2738